BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-988. [PMID: 21883740 DOI: 10.1111/j.1872-034x.2011.00851.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Liau SS, Qureshi MS, Praseedom R, Huguet E. Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg. 2013;17:1869-1882. [PMID: 23835731 DOI: 10.1007/s11605-013-2274-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
3 Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 2016;22:199-211. [PMID: 27189732 DOI: 10.3350/cmh.2016.0101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
4 Kim SM, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Hong SM. Clinicopathological features and post-resection outcomes of hepatocellular adenoma. Ann Hepatobiliary Pancreat Surg 2021;25:25-33. [PMID: 33649251 DOI: 10.14701/ahbps.2021.25.1.25] [Reference Citation Analysis]
5 Geramizadeh B, Memar Z, Malekhosseini S. Immunohistochemical Classification of Hepatic Adenoma, A Single Center Experience. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.91641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Inaba K, Sakaguchi T, Kurachi K, Mori H, Tao H, Nakamura T, Takehara Y, Baba S, Maekawa M, Sugimura H, Konno H. Hepatocellular adenoma associated with familial adenomatous polyposis coli. World J Hepatol 2012; 4(11): 322-326 [PMID: 23293720 DOI: 10.4254/wjh.v4.i11.322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013;2013:268625. [PMID: 23691331 DOI: 10.1155/2013/268625] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
8 Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5:HEP04. [PMID: 30302195 DOI: 10.2217/hep-2017-0023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ozaki K, Harada K, Yamamoto T, Aoyagi H, Kaizaki Y, Yoshikawa J. Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance. Clin J Gastroenterol 2018;11:75-82. [PMID: 29116626 DOI: 10.1007/s12328-017-0788-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
10 Koya Y, Suzuki T, Tai M, Ichii O, Matsuhashi N, Ejiri Y, Miyazawa M, Shibata M, Harada M, Kumabe T, Nakashima O. Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males. Intern Med 2019;58:1739-46. [PMID: 30799343 DOI: 10.2169/internalmedicine.1958-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
11 Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013;2013:604860. [PMID: 23509632 DOI: 10.1155/2013/604860] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
12 Kato K, Abe H, Hanawa N, Fukuzawa J, Matsuo R, Yonezawa T, Itoh S, Sato Y, Ika M, Shimizu S, Endo S, Hano H, Izu A, Sugitani M, Tsubota A. Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. Clin J Gastroenterol. 2018;11:401-410. [PMID: 29589251 DOI: 10.1007/s12328-018-0854-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kim H, Park YN. Hepatocellular adenomas: recent updates. J Pathol Transl Med 2021;55:171-80. [PMID: 33823565 DOI: 10.4132/jptm.2021.02.27] [Reference Citation Analysis]
14 Wang X, Zhang X. Hepatocellular adenoma: Where are we now? World J Gastroenterol 2022; 28(14): 1384-1393 [DOI: 10.3748/wjg.v28.i14.1384] [Reference Citation Analysis]
15 Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Diagn Pathol. 2016;11:27. [PMID: 26961851 DOI: 10.1186/s13000-016-0475-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
16 Kanda H, Furuta R, Motoi N, Kakita T, Sugiura Y, Unno T, Matsueda K, Saiura A, Sugitani M, Ishikawa Y. A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern. Clin J Gastroenterol 2015;8:426-34. [PMID: 26589902 DOI: 10.1007/s12328-015-0614-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol. 2013;2013:417323. [PMID: 23509631 DOI: 10.1155/2013/417323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Kim H, Jang JJ, Kim DS, Yeom BW, Won NH. Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases. Korean J Pathol 2013;47:411-7. [PMID: 24255628 DOI: 10.4132/KoreanJPathol.2013.47.5.411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
19 Galia M, Taibbi A, Marin D, Furlan A, Dioguardi Burgio M, Agnello F, Cabibbo G, Van Beers BE, Bartolotta TV, Midiri M, Lagalla R, Brancatelli G. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 2014;20:222-8. [PMID: 24509186 DOI: 10.5152/dir.2014.13184] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
20 Sasaki M, Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol 2012;2012:648131. [PMID: 22973519 DOI: 10.1155/2012/648131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]